Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients

BACKGROUND: Although the efficacy of iron sucrose (IS) and ferric carboxymaltose (FCM) in treating anemia in hemodialysis (HD) patients has been studied individually, a comparison of these two intravenous iron formulations has not yet been performed in HD patients. METHODS: We performed a retrospect...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMC Nephrol
Huvudupphovsmän: Hofman, Jesse M. G., Eisenga, Michele F., Diepenbroek, Adry, Nolte, Ilja M., van Dam, Bastiaan, Westerhuis, Ralf, Bakker, Stephan J. L., Franssen, Casper F. M., Gaillard, Carlo A. J. M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2018
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6149056/
https://ncbi.nlm.nih.gov/pubmed/30236065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-018-1045-8
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk